Ajmaline: Clinical Trials

4 trials of Ajmaline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Unknown 1
Phase 41Completed 1

Follow Ajmaline: new trials by email Literature Review of Ajmaline trials Research Report on Ajmaline

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Defining the Electrocardiographic Effect of Propofol on the Ajmaline Provocation Drug Challenge: A Prospective Trial
Ajmaline - Brugada Syndrome, Channelopathies
UnknownUniversitair Ziekenhuis Brussel252020-11-162021-12-08
The Response To Ajmaline Provocation in Healthy Subjects
Ajmaline - Brugada Syndrome, Sudden Death
Phase 2UnknownSt George's, University of London1002017-10-222019-11-05
Epicardial Ablation in Brugada Syndrome
mapping/ablation, Ajmaline, ablation - Brugada Syndrome
Not applicableCompletedIRCCS Policlinico S. Donato1352015-11-162018-01-17
Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
flecainide, ajmaline, procainamide - Atrial Fibrillation, Tachycardia, Ventricular
Phase 4CompletedHospital Clinic of Barcelona1232008-06-012010-12-15

Conditions studied

Brugada Syndrome (4)  ·  Death, Sudden (2)  ·  Atrial Fibrillation (1)  ·  Channelopathies (1)  ·  Death (1)  ·  Syncope (1)  ·  Tachycardia, Ventricular (1)  ·  Ventricular Fibrillation (1)

Sponsors

Hospital Clinic of Barcelona (1)  ·  IRCCS Policlinico S. Donato (1)  ·  St George's, University of London (1)  ·  Universitair Ziekenhuis Brussel (1)

Countries

Belgium (1)  ·  Italy (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Carlo Pappone, MD (1)  ·  Elijah Behr, MD (1)

Results publications

PMID 1309182, PMID 21403098, PMID 26291334, PMID 28500178, PMID 29650119, PMID 31647530

NIH funding

2016 (1)